OLP and lichenoid tissue reactions Flashcards

1
Q

what is lichen planus

A

a common chronic immune mediated mucocutaneous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where can it commonly affect

A
  • mucosa
    -skin
    -ano-genital mucosa

more rare
- pharynx
-conjunctiva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

difference between OLP and OLL

A
  • clinically look identical
  • similar histopathological features
  • OLP - no specific identifiable etiological factor

OLL- identifiable aetiological factor or manifestation of systemic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

OLR ??

A

reaction - caused by drug or material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical problems associated with OLP and OLL

A
  • very common
  • often painful
  • no cure
  • can be a manifestation of systemic disease
  • it has a 1% risk of malignant transformation over 10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

epidemiology of OLP/OLL

A
  • commonly presents between the ages of 30-65
  • slight female predilection
  • no racial predilection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

genetics role in OLP/OLL

A
  • association with HLA - which codes for how our immune system works
    an association with genes encoded at Chromosome 6 (where MHC is encoded) and lichen planus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

factors which increase OLP/OLL risk

A
  • immune system - CD8 and 4
  • genetic - HLA type
    environment - trauma, stress, medication, restorative materials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

immunopathogenesis of OLP

A
  • dependent on adaptive immune responce
  • CD8+ T cell mediated destruction of basal keratinocytes
  • these cells activated in lymph node by antigen-presenting cells expressing MHC I
  • they recognise an antigen presented on MHC I on basal keratinocytes
  • upon recognition of antigen release of granzyme and perforin to disrupt the cell membrane leading to cell death
    also release of TNF- alpha - influnce CD4+ T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

risk factors for OLP/OLL

A
  • stress
  • genetics
  • medications
  • dental materials
  • viral infection
  • chronic trauma
  • lupus - can present as a lichenoid lesion
  • graft versus host disease
  • diabetes
  • hypertension
  • autoimmune diseases
  • nutritional deficiency - can exacerbate symptoms
  • sodium lauryl sulphate - foaming agent in toothpaste
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what things in social history increase malignancy risk

A
  • smoking
  • alcohol
    -betel
  • low socioeconomic status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical features of OLP/OLL

A

white patch
- red patch - desquamative gingivitis
- erosion/ulcer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the types of OLP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is reticular OLP

A
  • reticular - net like pattern
    -lacy appearance
  • asymptomatic
    -spontaneously resolve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is atrophic OLP

A
  • red mucosa
  • thinning of mucous membrane
  • desquamative gingivitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is papular OLP

A
  • multiple white papules
    uncommon
17
Q

what is erosive OLP

A
  • erosions - similar appearance to an ulcer but resemble partial loss of epithelium
  • if there is an ulcer in OLP/OLL it is still termed erosive
  • symptomatic
  • risk of malignant chance
  • keep close eye
    -irregular pattern
18
Q

what is plaque like OLP

A
  • thickened white plaque
  • similar to white patches
19
Q

what is bullous OLP

A
  • uncommon
  • superficial mucoceles
20
Q

where is common in mouth for OLP/OLL

A
  • bilateral/symmetrical
  • buccal mucosa and tongue most common
  • if OLTR - then might be near etiological factor
  • if on palate and floor - consider lupus
21
Q

differences in clinical features of OLP and OLTR

22
Q

what to say to patient if diagnosed with OLP/OLL

A
  • describe what it is
    -non curable
    -immune mediated
  • caused by - genetics, environment
  • common
    -range of TX
  • risk of malignant change
23
Q

management of OLP and OLL

A
  • clinical photos
  • OHI and PMPR If desquamative
    -change amalgam restorations
  • SLS free toothpaste
  • refer
    -symptomatic relief
24
Q

when would you refer OLP/OLL

A
  • symptomatic
  • unilateral/non-symmetrical distribution
  • any non-reticular lichen planus
  • unclear diagnosis
  • the patient has other risk factors for malignant change
  • you think a biopsy is indicated
  • on side of tongue lesion - always refer - high malignant potential
25
Q

what is symptomatic relief for OLP/OLL

A

-benxydamine 0.15% MV or spray
- betamethasone MW 500mcg
if 1 highly localised lesion then beclomatasone 50 mcg inhaler
- hydrocortisone oromucosal tablet - 2.5mg

26
Q

what is management of OLP/OLL in secondary care

A
  • same as primary
  • exclude systemic disease
  • if symptomatic or erosive - FBC, haematinics , oral rinse to exclude final infection
27
Q

risks of biopsy

A
  • pain
    -bleeding
  • swelling
  • infection
    -altered sensation
28
Q

benefits of biopsy

A
  • confirms diagnosis
  • may identify dysplasia
  • can exclude vesicuobullous
29
Q

what are types of biopsy

A
  • Incisional biopsy for H & e staining
  • If wishing to exclude blistering disease also undertake incisional biopsy for Direct Immunofluorescence
  • An incisional punch or free-hand ellipse is generally appropriate
30
Q

what as histological features of OLP/OLL

A
  • death of basal keratinocytes/liquefaction
  • colloid bodies (sometimes called civatte bodies)
  • band like lymphocytic infiltrate - almost exclusively T cells
    • higher CD8+ T cell frequency
  • acanthosis
  • hyperparakeratosisi or hyperorthokeratosis
  • saw tooth rete pegs
  • epithelial atrophy or erosion
  • ?features of dysplasia
31
Q

management of OLP and OLL

A
  • remove amalgam
  • possible stop medication
  • topical steroid
  • potent topical steroid
    -systemic steroids
    -topical cacineurin inhibitors
    -hydroxychloroquine
    -azathioprine
    -mycophenolate mofetil
32
Q

what are names of some medications used for OLP and OLL

A

-topical steroids
-prednisolone (systemic steroid)
- potent topical steroids (cobetasol of flucocinolone)
- topical calcineurin inhibitors (tacrolimus)
- hydoxychloroquine
- azathioprine (DMARD)

33
Q

what is considered in high risk groups of patients with OLP/OLL

34
Q

if recent stem cell transplant what should be considered

35
Q

if palatal distribution of OLP and systemic features like joint pain and rash what should be considered

36
Q

what blood tests can be done for lupus

A
  • anti-nuclear antibodies
  • biopsy
  • anti-smith
  • anti-dsDNA
  • complement
  • immunoglobulins and protein electrophoresis
37
Q

what are white areas over skin lesions termed in LP

A

wickhams striae

38
Q

risks of cancer in OLP/OLL

A
  • increase in symptom severity
  • new lesions
  • new onset ulcers
  • exophytic lesions
  • erythema
  • dysphagia
  • lymphadenopathy
  • erosive
    -tongue lesions